Literature DB >> 6325325

Alteration of steroid hormone sensitivity during the cultivation of human mammary carcinoma cells.

W E Simon, M Hänsel, M Dietel, L Matthiesen, M Albrecht, F Hölzel.   

Abstract

During early cultivation steps of the newly derived and karyotyped human mammary carcinoma line EFM-19, the cells developed faster growth rates and became increasingly less responsive to the presence of serum in the culture medium. No drastic alterations of the morphology and of the karyotype were observed, and carcinoembryogenic antigen remained expressed during the course of the cultivation. In experimental incubations at various time intervals after the explantation, the cell proliferation was analyzed for dose-dependent effects of estradiol, cortisol, progesterone, and testosterone. After 16 wk of cultivation of the stock culture in the presence of estradiol, the cells had acquired a distinct sensitivity to estradiol resulting in permanent growth enhancement. The withdrawal of cortisol from the medium of the stock culture subsequently provoked the loss of the initially noted stimulation of the proliferation by cortisol. The stimulatory effect of progesterone on the proliferation was reversed to inhibition when the stock culture was deprived of cortisol in the growth medium. The results indicate that the choice of steroid hormones in the stock culture medium was determining the quality of the cellular growth responses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325325     DOI: 10.1007/bf02618184

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  24 in total

1.  Fetal bovine serum: a multivariate standard.

Authors:  K V Honn; J A Singley; W Chavin
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

2.  Cloned mouse mammary cell lines requiring androgens for growth in culture.

Authors:  W J Desmond; S J Wolbers; G Sato
Journal:  Cell       Date:  1976-05       Impact factor: 41.582

3.  G-6-PD and PGM phenotypes of 16 continuous human tumor cell lines. Evidence against cross-contamination and contamination by HeLa cells.

Authors:  G Beckman; L Beckman; J Pontén; B Westermark
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

4.  Influence on parathyroid hormone storage in normal and adenomatous parathyroid tissue by stimulation and inhibition in vitro.

Authors:  M Dietel; F Hölzel
Journal:  J Histochem Cytochem       Date:  1983-02       Impact factor: 2.479

5.  Growth inhibitory effects of thyroid hormones on androgen-dependent mammary tumor cells.

Authors:  C Natoli; G Sica; V Natoli; G Scambia; S Iacobelli
Journal:  J Steroid Biochem       Date:  1981-12       Impact factor: 4.292

6.  Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D).

Authors:  D Chalbos; F Vignon; I Keydar; H Rochefort
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

7.  Progression from hormone dependence to autonomy in mammary tumors as an in vivo manifestation of sequential clonal selection.

Authors:  U Kim; M J Depowski
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

8.  Chromosomes and cancer: new nomenclature and future directions.

Authors:  J J Yunis
Journal:  Hum Pathol       Date:  1981-06       Impact factor: 3.466

9.  Cytogenetic features of human neuroblastomas and cell lines.

Authors:  G M Brodeur; A A Green; F A Hayes; K J Williams; D L Williams; A A Tsiatis
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

10.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

Authors:  J Whang-Peng; C S Kao-Shan; E C Lee; P A Bunn; D N Carney; A F Gazdar; J D Minna
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

View more
  7 in total

1.  Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth.

Authors:  R Hackenberg; J Hofmann; G Wolff; F Hölzel; K D Schulz
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor.

Authors:  R Hackenberg; T Hawighorst; A Filmer; A H Nia; K D Schulz
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

3.  Effectiveness of antineoplastic drugs on the proliferation of human mammary and ovarian carcinoma cells in monolayer culture.

Authors:  F Hölzel; M Albrecht; W E Simon; M Hänsel; R Metz; J Schweizer; M Dietel
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

4.  Individual chemosensitivity of in vitro proliferating mammary and ovarian carcinoma cells in comparison to clinical results of chemotherapy.

Authors:  M Albrecht; W E Simon; F Hölzel
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

5.  Effects of tamoxifen on human breast cancer cells in vitro.

Authors:  W E Simon; G Trams; F Hölzel
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

6.  Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells.

Authors:  R Hackenberg; J Hofmann; F Hölzel; K D Schulz
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

7.  Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.

Authors:  D J DeFriend; E Anderson; J Bell; D P Wilks; C M West; R E Mansel; A Howell
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.